Researchers focused on accelerating and testing new treatments for low-grade brain tumors are set to receive a transformative £2.8 million to drive their future work.

The most common type of primary brain tumor is meningioma', a tumor that occurs in the meninges surrounding the brain. Most ...

Vivace Therapeutics Inc. reported preclinical efficacy data of VT-3989, a TEAD inhibitor, in in vitro and in vivo models of aggressive meningioma. VT-3989 is in early clinical development for the ...

A new study has shown that a clinical tool developed by the University of Liverpool and The Walton Center can accurately ...

1 in 4 sexually active women has used injectable birth control, administered into the muscle by a clinician, but many may be unaware of its association with meningioma, the most common brain tumor in ...

NEW YORK (PIX11) — Hundreds of women who used Depo-Provera and later developed brain tumors are suing Pfizer. Miller & Zois, Attorneys at Law, is one of the few firms interviewing women who have ...

Decades after receiving regular injections of the hormonal contraceptive Depo-Provera, an estimated 1,300 women are now suing manufacturer Pfizer, alleging the company failed to adequately warn users ...

WESTWEGO, Louisiana — Robin Phillip’s fresh haircut is dyed her favorite color — green. But beneath the dye job is a scar that runs along the side of her head, the result of two craniotomies. For ...

Contraception is often used to prevent pregnancies and manage menstrual cycles—which is exactly why Sandra Somarakis, now 61, and Nicole Ryan, 60, chose it for over a decade. Both women opted for ...

As of 2025, lawsuits are now underway against Pfizer, the manufacturer of Depo-Provera, filed by women who were diagnosed with meningioma after using the birth control shot. These cases allege that ...

Pfizer (NYSE:PFE) is facing an increasing number of lawsuits in the U.S. over its alleged failure to warn that its Depo-Provera contraceptive injection for women can cause a brain tumor called ...